Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density.
Weinstein
R S
RS
Division of Endocrinology/Metabolism, University of Arkansas for Medical Sciences, Little Rock, USA.
D000328:Adult; D015519:Bone Density / Q000187:drug effects*; D002136:Calcium, Dietary / Q000008:administration & dosage; D003094:Collagen / Q000652:urine; D024042:Collagen Type I; D004164:Diphosphonates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D005357:Fibrous Dysplasia of Bone / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D010146:Pain / Q000188:drug therapy; D000077268:Pamidronate; D010455:Peptides / Q000652:urine; D044465:White People
D002136:Calcium, Dietary; D024042:Collagen Type I; D004164:Diphosphonates; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D003094:Collagen; D000077268:Pamidronate